Key Documents
Pak H. Chan
- Professor, Neurosurgery
Contact Information
- Clinical Offices
- Academic Offices
Personal Information Email phchan@stanford.edu
Administrative Appointments
- Director of Research, Department of Neurosurgery, Stanford University School of Medicine , (1997– present )
Honors and Awards
- James R. Doty Professor of Neurosurgery and Neurosciences, Stanford University (2007)
- Mencius Type A & Type B Scholarships, Chinese University of Hong Kong (1960-1961)
- University Scientific Achievement Scholarship, Chinese University of Hong Kong (1962-1963)
- Jacob Javits Neuroscience Investigator Award, National Institutes of Health (1997-2004)
- Bugher Foundation Award, American Heart Association (2001-2004)
- Chairman, 22nd Princeton Conference on Cerebrovascular Disease (2000)
- President, National Neurotrauma Society (2000-2001)
- Member, Neurology A Study Section (1985-1989)
- Member, NINDS Neurological Disorders Program Project Review A Committee (1996-2000)
- Co-Chair, Neurovascular Protective Mechanisms, NINDS Stroke Progress Review Group (July 15-18, 2001)
- Member, NINDS Stroke Progress Review Group (January 6, 2003)
- Member, NIMH Board of Scientific Counselors (April 27-28, 2003)
- Invited Speaker and Participant, Spinal Cord Injury Workshop, National Academy of Sciences USA (May 24, 2004)
- Member, External Scientific Review Committee, Canadian Stroke Network (2004-present)
- Thomas Willis Award, American Stroke Association (2008)
Professional Education
- BS, Chinese University of Hong Kong Biology (1964)
- MA, UCLA Biochemistry (1970)
- PhD, UCLA Biology (1972)
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Research Interests
My primary research interest is to understand the molecular and cellular mechanisms of cell death in the CNS following acute injuries such as ischemia and trauma and chronic neurodegenerative diseases. We focus on the role of oxidative stress, mitochondrial dysfunction, DNA damage and repair, various gene expressions (gene family of HSP72, Bcl-2, c-fos and COX-2) and various transcription factors (NF-kappaB, AP1, p53) in the pathogenesis of necrosis and/or apoptosis. Various transgenic and knockout mutant mice of CuZn-superoxide dismutase (SOD1) and mitochondrial manganese SOD (SOD2) have been generated to address the role of superoxide radicals in these cell death processes. In addition, human SOD1 transgenic rats have been established as a model for the study of oxidative mechanisms and acute and chronic CNS injuries. The long-term goal of our research is to derive therapeutic strategies at the cellular and molecular level to ameliorate cell death in CNS injuries.
Publications
- J Neurosci. 2009; (21): 7003-14
- Stroke. 2009; (7): 2512-8
- J Neurochem. 2009; 133-8
- J Cereb Blood Flow Metab. 2009; (7): 1262-72
- Stroke. 2009; (4): 1467-73
- Biochim Biophys Acta. 2009;
- Stroke. 2009; (2): 618-25
- J Cereb Blood Flow Metab. 2008; (12): 1917-26
- J Cereb Blood Flow Metab. 2008; (10): 1686-96
- J Neurotrauma. 2008; (3): 184-95
- J Cereb Blood Flow Metab. 2008; (1): 44-52
- Proc Natl Acad Sci U S A. 2008; (42): 16368-73
- J Cereb Blood Flow Metab. 2007; (3): 521-33
- J Clin Invest. 2007; (4): 910-8
- Stroke. 2007; (3): 1044-9
- J Cereb Blood Flow Metab. 2007; (5): 975-82
- J Cereb Blood Flow Metab. 2007; (4): 764-75
- Stroke. 2006; (8): 2140-6
- Stroke. 2006; (4): 1116-9
- J Neurosci. 2006; (30): 7974-83
- J Cereb Blood Flow Metab. 2006; (8): 1076-88
- J Cereb Blood Flow Metab. 2006; (12): 1479-89
- J Neurosci. 2006; (16): 4329-37
- Ann Neurol. 2006; (6): 929-38
- J Neurotrauma. 2006; (5): 595-603
- Glia. 2006; (4): 360-5
- Stroke. 2006; (2): 513-7
- Biochem Soc Trans. 2006; (Pt 6): 1283-6
- Biochem Soc Trans. 2006; (Pt 6): 1366-9
- Mol Neurobiol. 2005; (1-3): 105-16
- J Neurochem. 2005; (2): 351-8
- J Cereb Blood Flow Metab. 2005; (2): 267-80
- Neurobiol Dis. 2005; (2): 491-9
- J Cereb Blood Flow Metab. 2005; (10): 1312-24
- J Cereb Blood Flow Metab. 2005; (1): 41-53
- Ann N Y Acad Sci. 2005; 203-9
- J Cereb Blood Flow Metab. 2005; (10): 1301-11
- Stroke. 2005; (6): 1264-9
- Stroke. 2004; (11 Suppl 1): 2748-50
- J Neurosci. 2004; (36): 7879-87
- Brain Res Mol Brain Res. 2004; (1-2): 89-95
- Stroke. 2004; (6): 1443-8
- Stroke. 2004; (5): 1169-74
- Neurobiol Dis. 2004; (2): 229-39
- J Neurosci. 2004; (7): 1584-93
- NeuroRx. 2004; (1): 17-25
- Neurochem Res. 2004; (11): 1943-9
- Stroke. 2004; (11): 2560-5
- J Cereb Blood Flow Metab. 2003; (10): 1117-28
- Antioxid Redox Signal. 2003; (5): 597-607
- Plast Reconstr Surg. 2003; (1): 251-5; discussion 256-7
- J Cereb Blood Flow Metab. 2003; (2): 166-80
- J Neurosci. 2003; (5): 1710-8
- Stroke. 2003; (6): 1513-8
- Brain Res Mol Brain Res. 2003; (1-2): 28-36
- J Neurochem. 2003; (6): 1431-42
- Brain Res. 2003; (1-2): 223-7
- J Cereb Blood Flow Metab. 2003; (8): 949-61
- J Neurotrauma. 2003; (6): 571-81
- J Cereb Blood Flow Metab. 2003; (9): 1010-9
- J Neurosci. 2003; (25): 8733-42
- J Neurotrauma. 2002; (1): 85-98
- Stroke. 2002; (3): 809-15
- Neurobiol Dis. 2002; (3): 294-304
- Glia. 2002; (3): 240-5
- J Cereb Blood Flow Metab. 2002; (7): 798-809
- J Neurosci. 2002; (1): 209-17
- J Neurosci. 2002; (18): 7923-30
- FASEB J. 2002; (14): 1997-9
- Neurobiol Dis. 2002; (1): 28-42
- J Cereb Blood Flow Metab. 2002; (1): 29-38
- Neuroscientist. 2002; (4): 323-34
- J Cereb Blood Flow Metab. 2001; (12): 1393-400
- J Cereb Blood Flow Metab. 2001; (12): 1442-50
- Neuroreport. 2001; (16): 3609-12
- J Cereb Blood Flow Metab. 2001; (1): 2-14
- FASEB J. 2001; (2): 525-34
- Stroke. 2001; (2): 506-15
- Neurobiol Dis. 2001; (1): 114-26
- Brain Res. 2001; (1-2): 208-13
- J Cereb Blood Flow Metab. 2001; (2): 163-73
- Stroke. 2001; (3): 741-7
- J Cereb Blood Flow Metab. 2001; (5): 557-67
- Stroke. 2001; (6): 1401-7
- Neurobiol Dis. 2001; (3): 380-90
- J Cereb Blood Flow Metab. 2001; (8): 914-20
- Stroke. 2001; (10): 2388-93
- Stroke. 2001; (10): 2356-61
- Neuroscience. 2001; (4): 1007-18
- J Cereb Blood Flow Metab. 2001; (8): 921-8
- Free Radic Biol Med. 2000; (10): 1571-6
- J Neurotrauma. 2000; (8): 713-8
- Brain Res. 2000; (2): 281-7
- Stroke. 2000; (10): 2450-9
- J Neurotrauma. 2000; (10): 871-90
- Nat Med. 2000; (2): 159-63
- J Cereb Blood Flow Metab. 2000; (1): 130-8
- J Neurosci. 2000; (8): 2817-24
- Brain Res. 2000; (2): 312-9
- Brain Res. 2000; (1-2): 105-11
- Neurochem Res. 2000; (5): 645-51
- J Cereb Blood Flow Metab. 2000; (12): 1690-701
- Neurosci Lett. 1999; (1): 61-4
- J Neurosci. 1999; (22): RC39
- Stroke. 1999; (2): 441-8; discussion 449
- Proc Natl Acad Sci U S A. 1999; (23): 13496-500
- Stroke. 1999; (11): 2456-62; discussion 2463
- Stroke. 1999; (11): 2408-15
- Brain Res. 1999; (1): 92-100
- Neuroscience. 1999; (4): 1465-73
- J Cereb Blood Flow Metab. 1999; (9): 1020-8
- Stroke. 1999; (9): 1962-8
- Neurosci Lett. 1999; (3): 201-5
- J Cereb Blood Flow Metab. 1999; (6): 634-42
- J Cereb Blood Flow Metab. 1999; (5): 495-501
- J Neurosci. 1999; (9): 3414-22
- J Cereb Blood Flow Metab. 1998; (11): 1239-47
- J Neurosci. 1998; (20): 8292-9